These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16103683

  • 1. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.
    Kołtowska-Haggstrom M, Hennessy S, Mattsson AF, Monson JP, Kind P.
    Horm Res; 2005; 64(1):46-54. PubMed ID: 16103683
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Using EQ-5D to derive general population-based utilities for the quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA).
    Kołtowska-Häggström M, Jonsson B, Isacson D, Bingefors K.
    Value Health; 2007; 10(1):73-81. PubMed ID: 17261118
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study.
    Gilet H, Chachuat A, Viala-Danten M, Auzière S, Koltowska-Häggström M.
    Value Health; 2010; 13(4):495-500. PubMed ID: 20102556
    [Abstract] [Full Text] [Related]

  • 9. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?
    Barkan AL.
    J Clin Endocrinol Metab; 2001 May; 86(5):1905-7. PubMed ID: 11344182
    [Abstract] [Full Text] [Related]

  • 12. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
    Svensson J, Mattsson A, Rosén T, Wirén L, Johannsson G, Bengtsson BA, Koltowska Häggström M, Swedish KIMS National Board.
    Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis.
    Wirén L, Whalley D, McKenna S, Wilhelmsen L.
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):143-52. PubMed ID: 10671940
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
    Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH, Wallaschofski H.
    Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [Abstract] [Full Text] [Related]

  • 18. Quality of life and growth hormone deficiency in adult patients in clinical evaluation and health economic assessment.
    Kołtowska-Häggström M.
    Pediatr Endocrinol Diabetes Metab; 2009 Nov; 15(3):203-9. PubMed ID: 20384183
    [Abstract] [Full Text] [Related]

  • 19. Quality of life in transition phase in adolescents and young adults with severe and partial growth hormone deficiency.
    Oswiecimska JM, Roczniak W, Romanowicz D, Szymlak A, Mikolajczak A, Malczyk Z, Stojewska M, Ziora KT.
    Neuro Endocrinol Lett; 2014 Nov; 35(8):676-83. PubMed ID: 25702295
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J, Finer N, Bouloux P, Bevan J, Jonsson B, Mattsson AF, Lundberg M, Harris PE, Koltowska-Häggström M, Monson JP, KIMS International Board.
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.